Filing Details
- Accession Number:
- 0001156039-25-000035
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-05 17:52:53
- Reporting Period:
- 2025-03-03
- Filing Date:
- 2025-03-05
- Accepted Time:
- 2025-03-05 17:52:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1156039 | Elevance Health Inc. | ELV | Hospital & Medical Service Plans (6324) | 352145715 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1887908 | Jr Morgan Charles Kendrick | 220 Virginia Ave Indianapolis IN 46204 | Evp & President, Commercial | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-03-03 | 2,221 | $395.50 | 7,089 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2025-03-03 | 2,845 | $0.00 | 9,934 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2025-03-03 | 3,686 | $0.00 | 13,620 | No | 4 | A | Direct | |
Common Stock | Disposition | 2025-03-05 | 3,504 | $396.30 | 10,116 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2025-03-03 | 10,828 | $0.00 | 10,828 | $395.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,828 | 2035-03-03 | No | 4 | A | Direct |
Footnotes
- PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
- Represents restricted share units. Restrictions lapse as follows: 948 shares each on 3/3/2026 and 3/3/2027, and 949 shares on 3/3/2028.
- Represents performance based restricted share units. Restrictions lapse on 3/3/2025.
- This transaction was executed in multiple trades, each at the same price of $396.30.
- Balance includes 22.89 shares acquired on December 20, 2024 through a dividend reinvestment plan.
- The option represents a right to purchase a total of 10,828 shares, and is exercisable in three annual installments, with two installments of 3,609 shares each and one installment of 3,610 shares, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.